PT Maja Agung Latexindo Tbk (ISX:SURI) EBITDA Margin % : 13.23% (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is PT Maja Agung Latexindo Tbk EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PT Maja Agung Latexindo Tbk's EBITDA for the three months ended in Sep. 2024 was Rp4,937 Mil. PT Maja Agung Latexindo Tbk's Revenue for the three months ended in Sep. 2024 was Rp37,310 Mil. Therefore, PT Maja Agung Latexindo Tbk's EBITDA margin for the quarter that ended in Sep. 2024 was 13.23%.

PT Maja Agung Latexindo Tbk EBITDA Margin % Historical Data

The historical data trend for PT Maja Agung Latexindo Tbk's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Maja Agung Latexindo Tbk EBITDA Margin % Chart

PT Maja Agung Latexindo Tbk Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

10.78

10.23

-5.47

1.20

PT Maja Agung Latexindo Tbk Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBITDA Margin %	Get a 7-Day Free Trial					19.53	-6.57	-4.11	-11.28	13.23

Competitive Comparison of PT Maja Agung Latexindo Tbk's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, PT Maja Agung Latexindo Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Maja Agung Latexindo Tbk's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Maja Agung Latexindo Tbk's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PT Maja Agung Latexindo Tbk's EBITDA Margin % falls into.

PT Maja Agung Latexindo Tbk EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PT Maja Agung Latexindo Tbk's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	978.074	/	81718.159
	=	1.20 %

PT Maja Agung Latexindo Tbk's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	4936.64	/	37310.051
	=	13.23 %

PT Maja Agung Latexindo Tbk (ISX:SURI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PT Maja Agung Latexindo Tbk EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PT Maja Agung Latexindo Tbk's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Maja Agung Latexindo Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Maja Agung Latexindo Tbk (ISX:SURI) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Utama No 98, Desa Pujimulyo, Kecamatan Sunggal, Kabupaten Deli Serdang, Sumatera Utara, IDN, 20352

Website

https://www.malgloves.com

PT Maja Agung Latexindo Tbk is engaged in the latex glove manufacturing industry. The business activities of the company are to engage in the rubber goods industry to support health needs, including contraceptive covers, pacifiers, compression devices, medical gloves, and urinary catheters. Its operating segments are; Gloves which generates the majority of the firm's total revenue, and Concentrated latex.